-
Mayor Ed Gainey said the Youth Civic Leadership Academy, launched Tuesday, will train the next generation of city leaders.
-
Three people are dead, and one other is wounded.
-
On today’s episode of The Confluence: Mayor Ed Gainey names the group of residents who will advise him on the selection of the city’s next police chief and explains how he hopes to spend federal dollars on infrastructure; and a preview of the city’s newest museum that plans to both highlight the past and train the future space industry workforce. Today’s guests include: Pittsburgh Mayor Ed Gainey; and Sam Moore, executive director of the Moonshot Museum.
-
Located in the heart of Homewood, the Greater Pittsburgh Coliseum has stood vacant for years. City officials had weighed two very different visions to redevelop it, but they found weaknesses in both plans, meaning the Coliseum will remain empty for some time to come.
-
Theresa Kail-Smith quit her post on the board in 2013 because she said she felt “blindsided” by actions taken by the authority that she said she wasn’t informed about until after the fact. She and labor leader Darrin Kelly have been nominated to fill vacant seats on the board.
-
Pittsburgh is removing a requirement for new police recruits to earn 60 college credits before the first day of police academy training.
-
Pittsburgh Mayor Ed Gainey unveiled his first city budget proposal Friday. It calls for a 7% increase in 2023 compared to what the city is spending in 2022.
-
Students will now have access to about 40 local companies where they can job shadow and complete other training, Mayor Ed Gainey announced Friday.
-
Some Pittsburgh Public Schools staff are haunted by whether a change in school district policy might have kept student Marquis Campbell away from school on the day he was shot.
-
The University of Pittsburgh announced ElevateBio would be the “anchor tenant” for a planned $250 million facility in Hazelwood Green. The Massachusetts-based company signed a 30-year agreement to occupy around half of the space. The company will manufacture cell and gene therapies that can be shipped all over the world.